Restrictive IL-10 induction by an innocuous parainfluenza virus vector ameliorates nasal allergy.
暂无分享,去创建一个
M. Kawano | E. Gabazza | H. Mizutani | T. Mabuchi | T. Nosaka | K. Yamanaka | K. Habe | K. Mizutani | Y. Matsushima | M. Kondo | H. Yamazaki | H. Inada | T. Nakanishi | A. Yamagiwa | M. Kakeda | K. Isono | K. Okada | Yoshiaki Matsushima | Chisami Hasegawa
[1] E. Gabazza,et al. Continuous high‐dose antigen exposure preferentially induces IL‐10, but intermittent antigen exposure induces IL‐4 , 2014, Experimental dermatology.
[2] M. Tsurudome,et al. Intranasally Administered Antigen 85B Gene Vaccine in Non-Replicating Human Parainfluenza Type 2 Virus Vector Ameliorates Mouse Atopic Dermatitis , 2013, PloS one.
[3] H. Mizutani,et al. The role of cytokines/chemokines in the pathogenesis of atopic dermatitis. , 2011, Current problems in dermatology.
[4] 欠田 成人. Induction of IL-10-producing regulatory T cells with TCR diversity by epitope-specific immunotherapy in pollinosis , 2010 .
[5] F. Sutterwala,et al. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. , 2006, Immunity.
[6] C. Akdis,et al. Immunological mechanisms of sublingual immunotherapy , 2006, Allergy.
[7] Y. Ito,et al. Recovery of infectious human parainfluenza type 2 virus from cDNA clones and properties of the defective virus without V-specific cysteine-rich domain. , 2001, Virology.
[8] C. Akdis,et al. Role of interleukin 10 in specific immunotherapy. , 1998, The Journal of clinical investigation.
[9] Y. Ito,et al. Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies. , 1989, Virology.